With this presence of cross-reactivity, epitopes Mu 1–17 and Hu/Mu 89–99, given the responses in a small cohort, could be used with an ovarian cancer mouse model to further explore the role of the anti-HSF1-PO4 immune response. The gene discussed is HSF1; the disease is ovarian carcinoma.